1. Reduced peripheral activity leading to hepato‐preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes1. (10th October 2016) Authors: Mudaliar, S.; Henry, R. R.; Ciaraldi, T. P.; Armstrong, D. A.; Burke, P. M.; Pettus, J. H.; Garhyan, P.; Choi, S. L.; Knadler, M. P.; Lam, E. C. Q.; Prince, M. J.; Bose, N.; Porksen, N. K.; Sinha, V. P.; Linnebjerg, H.; Jacober, S. J. Journal: Diabetes, obesity & metabolism Issue: Volume 18(2016)Supplement 2 Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials. Issue 3 (27th November 2018) Authors: Senior, P. A.; Pettus, J. H. Journal: Diabetic medicine Issue: Volume 36:Issue 3(2019) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗